about
Drug dosage in isolated limb perfusion: evaluation of a limb volume model for extremity volume calculationLower limb function and quality of life after ILP for soft-tissue sarcoma.Inhibition of KIT-glycosylation by 2-deoxyglucose abrogates KIT-signaling and combination with ABT-263 synergistically induces apoptosis in gastrointestinal stromal tumor.TNF-alpha and melphalan-based isolated limb perfusion: no evidence supporting the early destruction of tumour vasculatureEffectiveness of regional chemotherapy with TNF-alpha/melphalan in advanced soft tissue sarcoma of the extremities.Inhibitor of Apoptosis Proteins (IAPs) are commonly dysregulated in GIST and can be pharmacologically targeted to enhance the pro-apoptotic activity of imatinib[Prefabrication of transplants in plastic surgery].TNF-alpha and melphalan-based isolated limb perfusion: no evidence supporting the early destruction of tumour vasculature.[Fractures close to the epiphysis in children. Part I: upper extremities]Increased shedding of soluble TNF-receptor 1 during hyperthermic TNF-α-based isolated limb perfusionTumor vascularization and histopathologic regression of soft tissue sarcomas treated with isolated limb perfusion with TNF-α and melphalanRetrospective lifetime estimation of failed and explanted diamond-like carbon coated hip joint ballsSample taking during orthopedic surgery: sensitivity and specificity using the BACTEC blood culture systemNeoadjuvant treatment improves capsular integrity and the width of the fibrous capsule of high-grade soft-tissue sarcomas[Sarcoma of the hand and wrist][Long-term functional results after sarcoma resection]
P50
Q21245599-17B0CBFD-7425-41B7-B596-0091969FB592Q33560777-8968BE49-C193-471F-9149-D3B50980ADF1Q35189301-96C6C4BC-3412-4D01-919A-CD11D094726AQ35690539-141FA0F2-752E-4F57-8285-F90281B6DD1FQ37130237-65684EC1-6384-4096-955D-B45B4FE61D89Q37520240-D1C8C230-871D-41AA-B0B6-A7B3C6BF99A6Q41465624-79378DE4-80A7-4AD6-8B8F-E792D771B5F1Q43104431-EAB91AFF-4D47-4389-B88D-E6BB009194C1Q81353611-8F51C67C-E65D-41FA-809D-79430841B14BQ82439414-7613F141-CF79-44DC-BC57-92A23DA11BD7Q83603520-D42A73DA-18BC-4A05-BDCD-60935F768F83Q83949354-2329B9AA-EB3D-4AEB-B434-3CAD56FBDA95Q84170953-A565CC9B-BDD7-45E8-9160-3F54ACF147CBQ85296125-F5493EA8-E7DB-4F74-B6BD-878452020508Q86906610-CF37B3AB-EF44-4CBF-9812-7795E6CC815EQ87402381-C8C7FC79-E957-4EDC-9CE8-25C273DAD2A9
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
L E Podleska
@en
L E Podleska
@nl
type
label
L E Podleska
@en
L E Podleska
@nl
prefLabel
L E Podleska
@en
L E Podleska
@nl
P31
P496
0000-0002-1011-7822